NEW YORK (GenomeWeb) – Enzo Biochem today announced that the New York State Department of Health has granted approval of its AmpiProbe-HCV assay for quantitative detection of Hepatitis C virus.

AmpiProbe is the firm's proprietary nucleic acid amplification and detection platform developed by scientists at the New York-based company. The approval means the firm can offer its test to residents of the state of New York.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Researchers describe a way to share data while keeping it secure, Agence France Presse reports.

In Science this week: genetic mutations typically associated with esophageal cancer are common in older, healthy individuals, and more.

India's Council of Scientific and Industrial Research has a new director-general, according to ScienceInsider.

A new study links more than a hundred genes to autism spectrum disorder, Discover's D-brief blog reports.